Ding N - Search Results

1

[Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].

Ping LY, Ding N, Shi YF, Sun L, Zheng W, Xie Y, Wang XP, Tu MF, Lin NJ, Ying ZT, Liu WP, Deng LJ, Zhan C, Tian L, Feng LX, Song YQ, Zhu J. Ping LY, et al. Among authors: ding n. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):78-84. doi: 10.7534/j.issn.1009-2137.2014.01.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 24598656 Chinese.

2

Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP.

Jin X, Ding H, Ding N, Fu Z, Song Y, Zhu J. Jin X, et al. Among authors: ding n, ding h. J Hematol Oncol. 2012 Aug 16;5:51. doi: 10.1186/1756-8722-5-51. J Hematol Oncol. 2012. PMID: 22897949 Free PMC article.

3

Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma.

Ding H, Jin X, Ding N, Fu Z, Song Y, Zhu J. Ding H, et al. Among authors: ding n. Cancer Cell Int. 2013 Jun 10;13:58. doi: 10.1186/1475-2867-13-58. eCollection 2013. Cancer Cell Int. 2013. PMID: 23758737 Free PMC article.

4

Aggressive behavior and elevated lactate dehydrogenase at baseline confer inferior prognosis in patients with primary cutaneous lymphoma.

Liu WP, Song YQ, Zheng W, Wang XP, Ding N, Zhu J. Liu WP, et al. Among authors: ding n. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):534-40. doi: 10.1016/j.clml.2013.04.011. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763922

5

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma.

Fu Z, Zhu J, Zheng W, Liu W, Ying Z, Xie Y, Wang X, Lin N, Tu M, Ping L, Deng L, Zhang C, Ding N, Song Y. Fu Z, et al. Among authors: ding n. Cancer Cell Int. 2014 Jan 18;14(1):5. doi: 10.1186/1475-2867-14-5. Cancer Cell Int. 2014. PMID: 24438119 Free PMC article.

6

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab.

Hu Y, Ding N, Jin X, Feng L, Ping L, Song Y, Zhu J. Hu Y, et al. Among authors: ding n. Cancer Cell Int. 2014 Mar 13;14(1):25. doi: 10.1186/1475-2867-14-25. Cancer Cell Int. 2014. PMID: 24624997 Free PMC article.

7

Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment.

Zheng X, Ding N, Song Y, Feng L, Zhu J. Zheng X, et al. Among authors: ding n. Cancer Cell Int. 2014 Apr 3;14(1):32. doi: 10.1186/1475-2867-14-32. Cancer Cell Int. 2014. PMID: 24693884 Free PMC article.

8

FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.

Liu F, Ding H, Jin X, Ding N, Deng L, He Y, Zhu J, Song Y. Liu F, et al. Among authors: ding n, ding h. DNA Cell Biol. 2014 Sep;33(9):616-23. doi: 10.1089/dna.2013.2333. Epub 2014 Jul 22. DNA Cell Biol. 2014. PMID: 25050883 Free PMC article.

9

Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent paclitaxel.

Ding N, Ping L, Shi Y, Feng L, Zheng X, Song Y, Zhu J. Ding N, et al. Biochem Biophys Res Commun. 2014 Oct 24;453(3):392-7. doi: 10.1016/j.bbrc.2014.09.097. Epub 2014 Sep 27. Biochem Biophys Res Commun. 2014. PMID: 25268318

10

Histone deacetylase 6 activity is critical for the metastasis of Burkitt's lymphoma cells.

Ding N, Ping L, Feng L, Zheng X, Song Y, Zhu J. Ding N, et al. Cancer Cell Int. 2014 Dec 5;14(1):139. doi: 10.1186/s12935-014-0139-z. eCollection 2014. Cancer Cell Int. 2014. PMID: 25546298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,995 results

Search Page

Filters